QHM-2025-9647 Intrahealth Limited (AQP Anticoagulation)

The NHS North East and North Cumbria Integrated Care Board, operating out of Sunderland, UK, has recently awarded a contract for the provision of Anticoagulation Services under the title "QHM-2025-9647 Intrahealth Limited (AQP Anticoagulation)." This falls within the services category, specifically blood analysis services. The process followed the Health Care Services (Provider Selection Regime) Regulations 2023 and utilised a direct award process.

The contract, valued at £372,631, is set to commence on 1st April 2025 and conclude on 31st March 2026. The procurement process is complete, having passed through the standstill period, with no conflicts of interest identified during the assessment. This procurement represents an opportunity for businesses specialising in healthcare services, particularly those capable of providing blood analysis and related healthcare support, to expand their portfolio.

Although the contract has been awarded to the existing provider, Intrahealth (Federation), this exemplifies how regulated healthcare procurement offers avenues for established and well-qualified companies to secure government contracts. Companies capable of meeting the contractual standards and demonstrating a strong track record in healthcare service provision could be in a favourable position in similar future tenders.